United Therapeutics develops advanced therapies for rare, life-threatening conditions, primarily pulmonary arterial hypertension (PAH). Through innovative pharmaceuticals and organ transplant technologies, it extends and improves patients' lives. Specialists and patients battling chronic lung and vascular diseases benefit most, along with those awaiting donor organs, as the company pioneers sustainable, bioengineered solutions.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends